Evidence map›Paper›PMID 41867549›Full record

ArticleACS omega2026

Copper(II)-5-chloro-2-hydroxybenzophenone Complexes with

Alexandre B de Carvalho, Marcos V Palmeira-Mello, Paulo N de Souza, Saulo H Mendes Abe, José Balena G Filho, Marcelo B Andrade, Rodrigo S Corrêa, Alzir A Batista, Javier Ellena

Abstract read
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Alexandre B de CarvalhoSao Carlos Institute of Physics, University of Sao Paulo, IFSC-USP, Sao Carlos, São Paulo 13566-590, Brazil.ORCID https://orcid.org/0000-0002-8699-6165
Marcos V Palmeira-MelloDepartment of Chemistry, Federal University of São Carlos (UFSCar), São Carlos, São Paulo 13565-905, Brazil.ORCID https://orcid.org/0000-0003-2550-5315
Paulo N de SouzaSao Carlos Institute of Physics, University of Sao Paulo, IFSC-USP, Sao Carlos, São Paulo 13566-590, Brazil.
Saulo H Mendes AbeDepartment of Chemistry, Federal University of São Carlos (UFSCar), São Carlos, São Paulo 13565-905, Brazil.
José Balena G FilhoNanotechnology National Laboratory for Agriculture (LNNA), EMBRAPA Instrumentation, São Carlos, São Paulo 13561-206, Brazil.ORCID https://orcid.org/0000-0003-1641-6476
Marcelo B AndradeDepartment of Chemistry, Institute of Exact and Biological Sciences, Federal University of Ouro Preto (UFOP), Ouro Preto, Minas Gerais 35402-136, Brazil.ORCID https://orcid.org/0000-0001-9137-8831
Rodrigo S CorrêaDepartment of Chemistry, Institute of Exact and Biological Sciences, Federal University of Ouro Preto (UFOP), Ouro Preto, Minas Gerais 35402-136, Brazil.ORCID https://orcid.org/0000-0003-2783-0816
Alzir A BatistaDepartment of Chemistry, Federal University of São Carlos (UFSCar), São Carlos, São Paulo 13565-905, Brazil.
Javier EllenaSao Carlos Institute of Physics, University of Sao Paulo, IFSC-USP, Sao Carlos, São Paulo 13566-590, Brazil.ORCID https://orcid.org/0000-0002-0676-3098

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Five novel heteroleptic copper-(II) complexes were synthesized and fully characterized. Unlike previously reported Cu-(II)-diimine systems, these complexes incorporate an O,O-chelating 5-chloro-2-hydroxybenzophenone (5-Cl2HBz) ligand, forming cytotoxic compounds active against A2780 (ovarian), A549 (lung), and MCF-7 (breast) cancer cells. The complexes were identified as [Cu-(5-Cl2HBz)-(phen)-(NO

Identifiers

PMID41867549
PMCPMC13000599

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.